Inactive Ingredient Search for Approved Drug Products

• Share
• Tweet
• Linkedin
• Pin it
• More sharing options
  • Linkedin
  • Pin it
• Email
• Print

You are Searching: Change and Deletion by Inactive Ingredient Name Beginning with V

	Quarter	Inactive Ingredient	Route of Administration	Dosage Form	Maximum Potency per unit dose	Maximum Daily Exposure	Status
9286	Q3 2021	VANILLIN	ORAL	TABLET	1.50 mg		MDE Replacement
9286	Q4 2021	VANILLIN	ORAL	TABLET		4.5 mg	MDE Replacement
9292	Q3 2021	VANILLIN	ORAL	TABLET, FILM COATED	0.94 mg		MDE Replacement
9292	Q4 2021	VANILLIN	ORAL	TABLET, FILM COATED		5 mg	MDE Replacement
9293	Q3 2021	VANILLIN	ORAL	TABLET, FILM COATED, EXTENDED RELEASE	0.80 mg		MDE Replacement
9293	Q4 2021	VANILLIN	ORAL	TABLET, FILM COATED, EXTENDED RELEASE		0.8 mg	MDE Replacement
9309	Q3 2021	VEGETABLE OIL, HYDROGENATED	ORAL	TABLET	40.00 mg		MDE Replacement
9309	Q4 2021	VEGETABLE OIL, HYDROGENATED	ORAL	TABLET		42 mg	MDE Replacement

 

 

FDA/Center for Drug Evaluation and Research
Office of Pharmaceutical Quality
Office of Policy for Pharmaceutical Quality
Mailbox for IID corrections IIDUpdate@fda.hhs.gov
Update Frequency: Quarterly

Data Through: September 30, 2021
Database Last Updated: October 21, 2021